Back

mBio

34 training papers 2019-06-25 – 2026-03-07

Top medRxiv preprints most likely to be published in this journal, ranked by match strength.

1
Genomic surveillance of human metapneumovirus in the United States, 2010-2025
2026-01-21 infectious diseases 10.64898/2026.01.18.26344359
#1 (8.2%)
Show abstract

Human metapneumovirus (HMPV) is a significant cause of acute respiratory illness in both children and adults, yet its genomic epidemiology remains understudied compared to other respiratory viruses. Here, we report an expanded genomic surveillance of HMPV in the United States, utilizing 325 newly sequenced samples from two cohorts: the household-based HIVE study (2010-2022) in Michigan and the multicenter IVY network (2022-2025) of hospitalized adults. Our analyses revealed the continued predomi...

2
The Decline in Influenza Antibody Titers and Modifiers of Vaccine Immunity from over Ten Years of Serological Data
2026-01-15 infectious diseases 10.64898/2026.01.07.25342310
#1 (5.0%)
Show abstract

Annual influenza vaccination is the cornerstone for seasonal protection, yet antibody responses are highly variable across individuals and over time. To systematically assess the determinants of this heterogeneity, we compiled 20,449 hemagglutination inhibition and neutralization titers from 4,540 participants enrolled in 14 new vaccine studies we conducted and 50 prior studies that collectively span 2010-2023. Seasonal effects dominated, with pre- and post-vaccination titers declining steadily ...

3
Genomic Analysis of Salmonella Typhi from a Typhoid Conjugate Vaccine Trial
2026-01-11 infectious diseases 10.64898/2026.01.06.25342561
Top 0.1% (3.6%)
Show abstract

BackgroundSalmonella enterica serovar Typhi (S. Typhi), the causative agent of typhoid fever, continues to pose a major public health challenge in many low- and middle-income countries (LMICs). The World Health Organization recommended typhoid conjugate vaccine (TCV) use in countries with a high burden of disease, and/or high rates of antimicrobial resistance (AMR). Recent introductions of TCVs into national immunisation programmes are expected to substantially reduce this burden. However, the i...

4
Vaccine-Elicited Antibody Responses to Influenza H3N2 Subclade K
2026-02-04 infectious diseases 10.64898/2026.02.02.26345378
Top 0.1% (3.6%)
Show abstract

Influenza H3N2 subclade K (J.2.4.1) is a genetic branch of H3N2 with 11 mutations in hemagglutinin and currently represents the dominant circulating influenza strain. We evaluated antibody responses to H3N2 subclade K before and after influenza vaccination in 46 healthy individuals. Our data show that baseline antibody responses to two H3N2 subclade K variants were lower than to other H1N1 and H3N2 strains and that antibody responses following vaccination were also less robust to the H3N2 subcla...

5
Metagenomic strain tracking reveals patterns of bacterial spread and the impact of water chlorination
2026-02-11 infectious diseases 10.64898/2026.02.08.26345864
Top 0.1% (3.6%)
Show abstract

Bacterial infections are a major cause of morbidity and mortality among children under five in low- and middle-income countries (LMICs). Children in LMICs are exposed to and colonized by a range of pathogenic bacteria, yet patterns of bacterial exchange between humans are not well known, in part because culturing and sequencing single bacterial isolates is labor-intensive. Here, we apply a machine learning strain tracking approach to metagenomic data from 511 stool samples from children and moth...

6
Longitudinal dynamics of respiratory microbiome composition in infants following new tracheostomy placement
2026-01-02 pediatrics 10.64898/2025.12.29.25342834
Top 0.1% (3.6%)
Show abstract

Abnormal respiratory microbiomes are reported in children with artificial airways, yet the timing and persistence of these disruptions have not been defined in infants following new tracheostomy placement. We conducted a prospective longitudinal study to characterize airway microbiome dynamics following new tracheostomy placement during early life, a critical period for microbiome development. Fifteen hospitalized infants <=12 months contributed 84 tracheal aspirate samples collected from day 1 ...

7
Inactivated Japanese encephalitis virus vaccination imprints fusion loop-biased antibody responses that are attenuated by repeated live-attenuated dengue vaccination
2026-03-02 infectious diseases 10.64898/2026.02.27.26347269
Top 0.2% (3.0%)
Show abstract

Immune imprinting, also known as immune history, is a core aspect of adaptive immunity that influences antibody responses to future antigen exposures. Nevertheless, the impact of sequential flavivirus vaccinations on epitope targeting and antibody activity in humans remains incompletely understood. This question is particularly important in regions where the inactivated Japanese encephalitis virus (JEV) vaccines and the live-attenuated dengue virus (DENV) vaccines are used, as both have been ass...

8
Tracking Candida auris in Communities via Wastewater: Facility-Level Surveillance and Targeted Sequencing
2026-02-02 epidemiology 10.64898/2026.01.30.26345237
Top 0.2% (2.7%)
Show abstract

Candida auris is a multidrug-resistant fungal pathogen that presents substantial challenges for healthcare facilities due to its high mortality rates among vulnerable populations. Six C. auris clades have been identified based on their susceptibility to antifungal treatment and environmental stressors. Identifying the circulating C. auris clade(s) is critical for understanding transmission and selecting a disease control strategy. To inform targeted implementation of community wastewater monitor...

9
Integrating measles wastewater and clinical whole-genome sequencing enables high-resolution tracking of virus evolution and transmission
2026-02-23 epidemiology 10.64898/2026.02.21.26346782
Top 0.2% (2.7%)
Show abstract

Measles outbreaks have surged globally in recent years, but current surveillance systems have limited capacity to monitor measles virus (MeV) transmission and evolution at population scale. Although MeV can be detected in wastewater, the public health potential of wastewater genomic surveillance for MeV remains largely unexplored. Here, we deploy sensitive, low-cost MeV wastewater genomic surveillance combining virus concentration, whole-genome amplicon sequencing, and bioinformatic analysis alo...

10
Normal Variability of Urinary Markers in Individuals with Spinal Cord Injury and Disease Using Intermittent Catheterization
Top 0.2% (2.0%)
Show abstract

Accurate diagnosis of urinary tract infection (UTI) in individuals with neurogenic lower urinary tract dysfunction (NLUTD) due to spinal cord injury or disease (SCI/D) remains a major clinical challenge. Standard diagnostic tools--including urine dipstick, urinalysis, and culture--lack population-specific reference ranges, and existing criteria are often insufficient to distinguish infection from background variability. To address this gap, we conducted a longitudinal study to define the range o...

11
Microbial Ecological Signatures Predict Pathogen Emergence and Multidrug Resistance in Cystic Fibrosis Airways up to a Year in Advance
2026-01-02 respiratory medicine 10.64898/2025.12.28.25342520
Top 0.2% (2.0%)
Show abstract

Chronic infections in cystic fibrosis (CF) emerge from gradual ecological transitions in the airway microbiome, yet early predictive markers remain poorly defined. We developed a new autoencoder-based framework that outperforms read-based or metagenome-assembled genome-based analyses at capturing the continuum from health-associated commensals to pathogen-dominated, antibiotic-tolerant communities. This improvement is achieved by integrating taxonomic and functional data from 127 sputum and bron...

12
Stability of Microbiome-Derived Fatty Acids in Self-Collected Samples: A Comparative Evaluation of Stool and Blood Matrices
2026-03-06 gastroenterology 10.64898/2026.03.05.26347712
Top 0.3% (1.9%)
Show abstract

Background Short-chain fatty acids (SCFAs) are widely used as functional readouts of gut microbial activity in vivo. The growing adoption of decentralised study designs and self-collection protocols has amplified the need for reliable room-temperature storage and shipment strategies. However, SCFAs volatility and the persistence of post-collection microbial metabolism raise concerns regarding pre-analytical stability and the interpretability of measured concentrations. Methods We assessed the te...

13
Mapping the specificity of H3N2 strain-specific and cross-reactive human neutralizing antibodies elicited by the 2025-2026 influenza vaccine
2026-02-22 infectious diseases 10.64898/2026.02.20.26346746
Top 0.3% (1.9%)
Show abstract

An H3N2 variant, named subclade K, continues to circulate widely during the 2025-2026 influenza season. This virus possesses a hemagglutinin (HA) protein that has eleven substitutions relative to the HA of the Northern Hemisphere 2025-2026 H3N2 vaccine strain. Many of these substitutions are in epitopes in well-characterized HA antigenic sites. Despite this, interim vaccine effectiveness studies indicate that the 2025-2026 influenza vaccine provides moderate protection against H3N2 subclade K in...

14
MY008211A in complement inhibitor-naive patients with paroxysmal nocturnal hemoglobinuria and signs of hemolysis
2026-02-06 hematology 10.64898/2026.02.05.26345159
Top 0.4% (1.8%)
Show abstract

Key pointsO_LIWe report findings from a phase 2 study of MY008211A among Chinese men and women aged [&ge;]18 years with paroxysmal nocturnal hemoglobinuria C_LIO_LIIncreases in hemoglobin of [&ge;]20 g/L were maintained for up to 44 weeks of treatment with MY008211A in all 34 patientsiv C_LI Explanation of noveltyParoxysmal nocturnal hemoglobinuria is characterized by red blood cell (RBC) destruction and a prothrombotic state.v Treatments exist such as complement 5 inhibitors but these carry th...

15
The Representativeness of Regional Influenza Virus Genomic Surveillance for National Trends in the United States
2026-03-02 infectious diseases 10.64898/2026.02.23.26346422
Top 0.4% (1.8%)
Show abstract

Genomic surveillance of influenza viruses informs vaccine strain selection and evolutionary forecasting. Sequencing efforts vary widely across U.S. states, which raises concerns about spatial sampling bias. We evaluated how well 10,958 influenza virus genomes sampled by our group in Michigan captured the genetic diversity in 34,743 genomes circulating nationally from the 2021/22 through 2024/25 seasons. We defined seasonal hemagglutinin haplotypes and tracked their detection across states. A sma...

16
CRISPR-Cas12a Assay for Rapid and Specific Detection of Shigella flexneri 2a in Clinical Samples
2025-12-22 infectious diseases 10.64898/2025.12.19.25342683
Top 0.4% (1.8%)
Show abstract

Shigella flexneri 2a is the most common cause of shigellosis, a major public health concern in developing countries. Rapid and reliable diagnostic tools are critical for timely outbreak detection and management. Leveraging Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) technology, we developed a CRISPR-Cas12a-based assay for the rapid and specific detection of S. flexneri 2a and validated its performance using stool specimens from patients. Two guide RNAs targeting the gtrII ...

17
Antibodies elicited by the 2025-2026 influenza vaccine in humans
2026-01-06 infectious diseases 10.64898/2026.01.05.26343449
Top 0.4% (1.8%)
Show abstract

A new H3N2 variant (named subclade K) possesses several key hemagglutinin substitutions and is circulating widely during the 2025-2026 influenza season. In this report, we completed experiments to determine if the 2025-2026 seasonal influenza vaccine elicits antibodies in humans that recognize this variant. We find that H3N2 subclade K viruses are antigenically advanced; however, the 2025-2026 seasonal influenza vaccine elicited antibodies in many individuals that efficiently recognized these vi...

18
The Mucosal Cytokine Landscape of Acute Gonorrhea Using a Controlled Human Infection Model
2026-02-25 infectious diseases 10.64898/2026.02.22.26346846
Top 0.5% (1.8%)
Show abstract

The host response to Neisseria gonorrhoeae is variable, and understanding its systemic and local components is critical to understanding anti-gonococcal immunity for vaccine development. We used a controlled human infection model of male gonococcal urethritis in naive volunteers in combination with multiplex cytokine analyte analysis of blood and urine specimens taken before infection, at the time of acute symptoms, and after curative treatment of N. gonorrhoeae to study responses to early infec...

19
Longitudinal assessment of functional antibodies to a novel influenza virus strain across age groups
2026-02-23 infectious diseases 10.64898/2026.02.21.26346781
Top 0.5% (1.8%)
Show abstract

Newly emerging influenza virus strains pose a constant threat as they encounter a population lacking neutralizing antibodies against the new strain. However, cross-reactive non-neutralizing antibodies (nnABs) may be present and assist in mitigating disease symptoms via various effector mechanisms, including antibody-dependent cellular cytotoxicity (ADCC). Although nnABs to influenza virus have received more attention lately, little information is available on their age-related prevalence, steady...

20
Subclade K influenza A (H3N2) viruses display partial immune escape with preserved cross-neutralisation in a UK population
2026-01-29 infectious diseases 10.64898/2026.01.27.26344933
Top 0.6% (1.6%)
Show abstract

We examined whether the recent emergence of influenza A(H3N2) subclade K, associated with an unusually early influenza season in the Northern hemisphere, was accompanied by a reduction in human population immunity. Using virus neutralisation assays on pre-epidemic human sera collected in May 2025, we found evidence of moderate antigenic drift. Further, vaccines used in the 2024/2025 season induced cross-neutralising immunity. These findings provide timely insight for interpreting recent influenz...